✦ LIBER ✦

Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

✍ Scribed by Shella Schirman; Sefi Kronenberg; Alan Apter; David Brent; Nadine Melhem; Nimrod Pick; Miri Carmel; Amos Frisch; Abraham Weizman; Doron Gothelf

Publisher: Springer
Year: 2009
Tongue: English
Weight: 176 KB
Volume: 117
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-009-0330-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

✍ Cengiz Akkaya; Enver Yusuf Sivrioglu; Semra Akgoz; Salih Saygin Eker; Selcuk Kir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Objective: The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (mdd) and mdd with anxiety features to venlafaxine xr. ## Method: Patients with mdd, aging 18 between 65 years, were randomly allocated to two groups receiv

Effectiveness and acceptability of sertr

Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison

✍ Prithpal S. Matreja; Dinesh K. Badyal; Prem Khosla; Randhir S. Deswal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objective Citalopram and sertraline are widely prescribed selective serotonin reuptake inhibitors (SSRIs). There is no conclusive evidence to show superiority of citalopram or sertraline in terms of efficacy or tolerability. Hence this study was designed to compare short term effica

Fluvoxamine is ineffective in the treatm

Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study

✍ Paz Toren; Sofia Eldar; Nathaniel Laor; Leo Wolmer; Eliahu Samuel; Ronit Weizman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Tricyclic antidepressants possess established antienuretic properties. The selective serotonin reuptake inhibitors (SSRIs) have similar antidepressant properties to the tricyclic antidepressants and a safer side effect profile. The aim of the present study was to evaluate the antienuretic efficacy o

Open-label study comparing the efficacy

Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders

✍ Hanik K. Yoo; Joong-Sun Lee; Kyoung-Won Paik; Soon-Ho Choi; Sujung J. Yoon; Jieu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 220 KB

Effectiveness and tolerability of paroxe

Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea

✍ Chi-Un Pae; Won-Myong Bahk; Duk-In Jon; Sang-Yeol Lee; Bo-Hyun Yoon; Kyung Joon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled

An open-label study of escitalopram (Lex

An open-label study of escitalopram (Lexapro®) for the treatment of ‘Depression of Alzheimer's disease’ (dAD)

✍ V. Rao; J. R. Spiro; P. B. Rosenberg; H. B. Lee; A. Rosenblatt; C. G. Lyketsos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract ## Background Depression is a frequent neuropsychiatric complication of Alzheimer's Disease. ## Methods This study investigated the safety and effectiveness of escitalopram (LEXAPRO) for depression in AD (dAD) as defined by the NIMH consensus criteria in an 8‐week, open‐label treatme